The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks.

Autor: Okumura T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. takaoku@med.nagoya-u.ac.jp., Murohara T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Jazyk: angličtina
Zdroj: Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2024 Sep; Vol. 47 (9), pp. 2598-2600. Date of Electronic Publication: 2024 Jul 01.
DOI: 10.1038/s41440-024-01772-x
Databáze: MEDLINE
Externí odkaz: